Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J AAPOS. 2017 Dec 6;22(1):61–65.e1. doi: 10.1016/j.jaapos.2017.10.006

Table 3.

Baseline characteristics of infants evaluated at follow-up

Characteristic Bevacizumab group
(n = 7)
Laser group
(n = 9)
Birth weight, g, mean (range) 678 (600–780) 605 (489–715)
GA, weeks, mean (range)   25.0 (23.7–26.0)   24.4 (23.4–25.7)
Race, n (%)
 Black     2 (29)     1 (11)
 White     0     4 (44)
 Hispanic     5 (71)     4 (44)
Sex, male, n (%)     5 (71)     5 (62)
PNA,a days, mean (range)   66 (54–76)   74 (63–86)
PMA,a weeks, mean (range)   34.5 (31.7–36.9)   35.0 (33.1–37.4)

GA, gestational age; PMA, postmenstrual age; PNA, postnatal age.

a

At enrollment into BEAT-ROP.